Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Case Report
2012:78:5;632-634
doi: 10.4103/0378-6323.100587

Childhood pemphigus vulgaris successfully treated with rituximab

Amrinder J Kanwar1 , Gitesh U Sawatkar1 , Keshavamurthy Vinay1 , Takashi Hashimoto2
1 Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, 67 Asahimachi, Kurume, Fukuoka 830-0011, Japan

Correspondence Address:
Amrinder J Kanwar
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh-160 012
India
How to cite this article:
Kanwar AJ, Sawatkar GU, Vinay K, Hashimoto T. Childhood pemphigus vulgaris successfully treated with rituximab. Indian J Dermatol Venereol Leprol 2012;78:632-634
Copyright: (C)2012 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.
Keywords: Autoimmune bullous diseases, childhood pemphigus vulgaris, rituximab

Introduction

Pemphigus is a relatively common autoimmune mucocutaneous blistering disorder in India and is caused by antibodies directed against desmosomal cadherins known as desmogleins (Dsg). The 2 main types of pemphigus are pemphigus vulgaris (PV) and pemphigus foliaceus (PF). In India, pemphigus occurs in a younger age group, commonly found in 3 rd and 4 th decades. In a study from north India, 75% of the patients were aged less than 45 years, and children aged less than 15 years accounted for 3.7% of cases. [1] PV in children aged less than 12 years is known as childhood PV and in those aged between 12-18 years as juvenile PV. [2] The disease course of childhood pemphigus and treatment modalities are essentially the same as those in adults. [3] Although corticosteroids are the mainstay of therapy, adjuvant immunosuppressive drugs are often needed to control the disease. Some childhood pemphigus patients are refractory to conventional treatments and require additional therapies.

Case Report

An 11-year-old boy presented with a 4-month-history of painful oral ulcers and flaccid fluid-filled blisters predominantly on the face and upper trunk, which ruptured to form progressive erosions with crusting. Tzanck smear from the floor of the vesicle showed acantholytic cells, and skin biopsy specimens showed suprabasal acantholysis with tomb stone appearance of basal keratinocytes. The results of direct and indirect immunofluorescence studies were consistent with a diagnosis of PV. The patient was started on dexamethasone pulse therapy (100 mg dexamethasone in 250 ml of 5% dextrose for 3 consecutive days every 28 days) with oral prednisolone 1 mg/kg/day and azathioprine 1.5 mg/ kg/day during the intervening period. There was partial improvement and cutaneous erosions healed, although new lesions continued to occur. Three weeks after receiving the 4 th course of dexamethasone pulse therapy, patient developed severe disease flare with extensive cutaneous erosions and new blisters [Figure - 1]a, and had an Ikeda severity score [4] (ISS) of 10. Blood cultures grew Klebsiella pneumoniae and Acinetobacter baumannii on two separate occasions, and he was treated with appropriate antibiotics. ELISA of recombinant Dsg baculoproteins for IgG antibodies at this point showed a Dsg1 index value of 102.77 and Dsg3 index value of 194.58 (cut-off value > 20). Because of persistent disease activity and failure of former therapies, it was decided to treat the patient with rituximab. Five weeks after the 4 th dexamethasone pulse, 2 courses of rituximab were administered at a dose of 375 mg/m 2 body surface area at 15 days interval. He also received prednisolone at a dose of 1 mg/kg/day, while all other therapies were stopped. The patient showed dramatic response. New lesions stopped to appear, and 80% of the lesions healed within 3 weeks and ISS was 3 [Figure - 1]b. Corticosteroids were rapidly tapered during the next 6 weeks. Dsg1 and Dsg3 ELISA index values detected 1 month after rituximab infusion were 109.76 and 124.37, respectively. He was in clinical remission for 8 months follow-up period, and all treatments stopped. ELISA tests could not be repeated as his parents refused the investigation.

Figure 1: Clinical features. (a) Prior to rituximab infusion, extensive erosions over the upper trunk were seen. (b) Three weeks after rituximab therapy, majority of the erosions healed

Discussion

Rituximab, a chimeric anti-CD20 antibody, targets an integral membrane protein involved in B-cell activation and proliferation. Use of rituximab has been indicated in pemphigus patients who fail to respond to conventional treatment or when their use is contraindicated. [5] Recent studies have shown long term safety and efficacy of rituximab in pemphigus patients. [6] However, use of rituximab is not recommended in children, mainly because of limited clinical experience in this age group. [5] Our patient had severe flare of the disease and did not improve with the conventional treatment modalities. He also developed life-threatening sepsis because of the secondarily infected skin erosions. Therefore, balancing the potential benefit and risk of harm, it was decided to treat him with rituximab. On review of the literature, we came across only 6 cases of childhood pemphigus treated with rituximab [Table - 1]. [6],[7],[8],[9],[10],[11] Two of these cases were PF and 4 were PV. However, 3 of the 4 childhood PV cases actually received rituximab therapy in their adolescence, although diagnoses were made before the age of 12 years. All cases of childhood pemphigus were treated with conventional modalities before rituximab therapy. These cases were generally resistant to conventional treatments or had severe adverse effects with these therapies. Most of the cases were treated with multiple infusions of rituximab with or without IVIG. In contrast, our case achieved clinical remission after only 2 rituximab infusions. None of the 6 previous cases showed any serious long-term adverse effects, although acute infusion reactions and systemic infections were found in some cases. [7],[11]

Table 1: The summary of clinical findings in childhood pemphigus cases treated with rituximab

In conclusion, rituximab can be a good alternative therapy in recalcitrant cases of childhood pemphigus. Long-term prospective studies of rituximab in childhood pemphigus with adequate sample size are required to determine its safety and efficacy.

References
1.
Kanwar AJ, Ajith AC, Narang T. Pemphigus in North India. J Cutan Med Surg 2006;10:21-5.
[Google Scholar]
2.
Gorsky M, Raviv M, Raviv E. Pemphigus vulgaris in adolescence. A case presentation and review of the literature. Oral Surg Oral Med Oral Pathol 1994;77:620-2.
[Google Scholar]
3.
Kanwar AJ, Dhar S, Kaur S. Further experience with pemphigus in children. Pediatr Dermatol 1994;11:107-11.
[Google Scholar]
4.
Ikeda S, Imamura S, Hashimoto I, Morioka S, Sakuma M, Ogawa H. History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan. Arch Dermatol Res 2003;295 Suppl 1:S12-6.
[Google Scholar]
5.
Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, et al. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges 2008;6:366-73.
[Google Scholar]
6.
Reguiai Z, Tabary T, Maizieres M, Bernard P. Rituximab treatment of severe pemphigus: Long-term results including immunologic follow-up. J Am Acad Dermatol Forthcoming 2012 Jan 18. doi: 10.1016/j.jaad.2011.12.019.
[Google Scholar]
7.
Connelly EA, Aber C, Kleiner G, Nousari C, Charles C, Schachner LA. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment. Pediatr Dermatol 2007;24:172-6.
[Google Scholar]
8.
Kong HH, Prose NS, Ware RE, Hall RP 3rd. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab). Pediatr Dermatol 2005;22:461-4.
[Google Scholar]
9.
Schmidt E, Herzog S, Brocker EB, Zillikens D, Goebeler M. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab. Br J Dermatol 2005;153:449-51.
[Google Scholar]
10.
Fuertes I, Guilabert A, Mascaro JM Jr., Iranzo P. Rituximab in childhood pemphigus vulgaris: A long-term follow-up case and review of the literature. Dermatology 2010;221:13-6.
[Google Scholar]
11.
Kanwar AJ, Tsuruta D, Vinay K, Koga H, Ishii N, Dainichi T, et al. Efficacy and safety of rituximab treatment in Indian pemphigus patients. J Eur Acad Dermatol Venereol Forthcoming 2011. [In Press]
[Google Scholar]

Fulltext Views
3,704

PDF downloads
2,425
Show Sections